Meta's Muse Image rollout lets public Instagram photos be used to generate AI images unless you opt out. Here’s the quick path to flip the setting.

California's new AI‑unemployment tracker finds no statewide surge, but college‑educated, highly AI‑exposed Bay Area tech workers have seen unemployment claims climb sharply.

Bay Area-built FireSat satellites launched Tuesday, promising higher-resolution wildfire detection and faster alerts for firefighters.

Microsoft is seeding a new "Frontier" company with $2.5 billion to help big firms deploy AI, promising customers will keep the work and IP from those projects.

A San Francisco judge refused to toss a major class action accusing Workday’s AI hiring tools of discriminating by race, age and disability. The decision keeps key claims alive.

Apple raised prices on Macs and iPads as AI-driven memory and storage costs surged, pushing some popular entry-level models up by hundreds of dollars. The company says it can no longer absorb soaring component bills.

Alphabet will enter the Dow next Monday, replacing Verizon and boosting tech's footprint in the 30-stock index. The swap highlights quirks in the Dow's price-weighted design.

Salem-based Agility Robotics agreed to merge with Churchill Capital XI in a deal that values the company at about $2.5 billion and aims to scale its RoboFab production. The transaction hinges on shareholder and SEC approvals.

Sunrun, Tesla and startups are pitching a plan to marshal rooftop solar, batteries and smart devices in millions of homes to free power for AI data centers during peak demand. Regulators and local communities are watching closely.

Menlo Ventures marked its 50th anniversary by announcing $3 billion across two AI funds aimed at seed‑to‑growth startups. The raise expands the firm’s bets in infrastructure, healthcare and enterprise AI.

Blocking an age‑linked enzyme regenerated hyaline cartilage in mice and produced early repair signals in human knee tissue, researchers report.

A tiny peptide called BRP cut meals in mice and minipigs and drove fat‑specific weight loss; human testing is not yet underway.

Cepheid opened a 180,000‑square‑foot Building 5 in Lodi on May 28, 2026, completing a multi‑building manufacturing campus and boosting local diagnostic production.